UK markets closed

KALA BIO, Inc. (0JQ2.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
6.52-0.17 (-2.54%)
At close: 04:21PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-49.67%
S&P500 52-week change 323.49%
52-week high 319.48
52-week low 30.00
50-day moving average 37.08
200-day moving average 311.17

Share statistics

Avg vol (3-month) 3320
Avg vol (10-day) 3117
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 82.31M
% held by insiders 18.36%
% held by institutions 125.75%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.02:1
Last split date 321 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-40.78%
Return on equity (ttm)-262.60%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -40.57M
Net income avi to common (ttm)-39.55M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)48.48M
Total cash per share (mrq)17.21
Total debt (mrq)36.56M
Total debt/equity (mrq)548.90%
Current ratio (mrq)4.22
Book value per share (mrq)2.37

Cash flow statement

Operating cash flow (ttm)-29.09M
Levered free cash flow (ttm)-19.3M